AGP Executive Report
Last update: 7 hours agoCrypto Regulation in Liechtenstein: Bitcoin Suisse (Europe) AG received a MiCAR Crypto Asset Service Provider license from Liechtenstein’s FMA, giving it a regulated base to serve selected EEA markets with trading, custody and staking. EU Financial Services: OpenPayd also secured MiCA authorization, enabling regulated fiat-to-stablecoin conversions, custody and stablecoin transfers across the EEA via a single API. Healthcare & Pharma (EU-wide, incl. Liechtenstein): Merck won EU approval for KEYTRUDA + Padcev as perioperative treatment for cisplatin-ineligible adults with resectable muscle-invasive bladder cancer, and Gilead’s Trodelvy gained EU marketing authorization for first-line metastatic TNBC ineligible for PD-1/PD-L1 therapy (also covering Norway, Iceland and Liechtenstein). Energy Transition: Offshore wind is being positioned as Asia’s next investment frontier, with the Philippines highlighted for its coastal wind potential and energy-security push. Local Industry & Trade: Liechtenstein Post’s role featured in the Macao 2026 stamp exhibition opening, underscoring how small-country craftsmanship still reaches global audiences.
Note: AI summary from news headlines; neutral sources weighted more to help reduce bias in the result. Feedback is welcome. Please let us know if you have any comments or suggestions about the AGP Executive Report.
Perspectify News
